ATE283857T1 - Imidazo(1,5-aöpyrimido)5,4-döbenz azepinderivate als gaba-a-rezeptormodulatoren - Google Patents

Imidazo(1,5-aöpyrimido)5,4-döbenz azepinderivate als gaba-a-rezeptormodulatoren

Info

Publication number
ATE283857T1
ATE283857T1 AT02771640T AT02771640T ATE283857T1 AT E283857 T1 ATE283857 T1 AT E283857T1 AT 02771640 T AT02771640 T AT 02771640T AT 02771640 T AT02771640 T AT 02771640T AT E283857 T1 ATE283857 T1 AT E283857T1
Authority
AT
Austria
Prior art keywords
döbenz
aöpyrimido
gaba
imidazo
receptor modulators
Prior art date
Application number
AT02771640T
Other languages
English (en)
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE283857T1 publication Critical patent/ATE283857T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT02771640T 2001-05-18 2002-05-08 Imidazo(1,5-aöpyrimido)5,4-döbenz azepinderivate als gaba-a-rezeptormodulatoren ATE283857T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18
PCT/EP2002/005121 WO2002094834A1 (en) 2001-05-18 2002-05-08 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators

Publications (1)

Publication Number Publication Date
ATE283857T1 true ATE283857T1 (de) 2004-12-15

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02771640T ATE283857T1 (de) 2001-05-18 2002-05-08 Imidazo(1,5-aöpyrimido)5,4-döbenz azepinderivate als gaba-a-rezeptormodulatoren

Country Status (37)

Country Link
US (1) US6686352B2 (de)
EP (1) EP1399448B1 (de)
JP (1) JP4068466B2 (de)
KR (1) KR100533406B1 (de)
CN (1) CN1230436C (de)
AR (1) AR033753A1 (de)
AT (1) ATE283857T1 (de)
AU (1) AU2002338898B2 (de)
BG (1) BG108369A (de)
BR (1) BR0209859A (de)
CA (1) CA2446903C (de)
CZ (1) CZ20033355A3 (de)
DE (1) DE60202147T2 (de)
DK (1) DK1399448T3 (de)
EC (1) ECSP034851A (de)
ES (1) ES2232778T3 (de)
GT (1) GT200200087A (de)
HR (1) HRP20030890A2 (de)
HU (1) HUP0400743A3 (de)
IL (2) IL158572A0 (de)
JO (1) JO2297B1 (de)
MA (1) MA27024A1 (de)
MX (1) MXPA03010529A (de)
MY (1) MY127570A (de)
NO (1) NO20035104L (de)
NZ (1) NZ529097A (de)
PA (1) PA8545201A1 (de)
PE (1) PE20030041A1 (de)
PL (1) PL366846A1 (de)
PT (1) PT1399448E (de)
RU (1) RU2287531C2 (de)
SI (1) SI1399448T1 (de)
SK (1) SK15252003A3 (de)
TW (1) TWI251489B (de)
WO (1) WO2002094834A1 (de)
YU (1) YU90003A (de)
ZA (1) ZA200308544B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101792651B1 (ko) 2004-05-14 2017-11-20 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 화합물을 포함하는 약학적 조성물
EP1799684B1 (de) * 2004-10-04 2014-12-03 Millennium Pharmaceuticals, Inc. Als proteinkinaseinhibotren geeignete lactamverbindungen
RU2007114763A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Галогенозамещенные производные бензодиазепинов
NZ554439A (en) * 2004-10-20 2009-09-25 Hoffmann La Roche Imidazo-benzodiazepine derivatives
JP4885967B2 (ja) 2005-10-11 2012-02-29 エフ.ホフマン−ラ ロシュ アーゲー イミダゾベンゾジアゼピン誘導体
PE20080145A1 (es) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
JP5562865B2 (ja) 2007-12-17 2014-07-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Trpv1のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
US7998952B2 (en) 2008-12-05 2011-08-16 Millennium Pharmaceuticals, Inc. Thiolactams and uses thereof
CN102264368B (zh) 2008-12-22 2014-09-10 米伦纽姆医药公司 极光激酶抑制剂与抗cd20抗体的组合
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
WO2011103089A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
EP2976086B1 (de) 2013-03-22 2020-10-14 Millennium Pharmaceuticals, Inc. Kombination aus katalytischen mtorc 1/2-inhibitoren und selektiven inhibitoren der aurora-a-kinase
EP4032889B1 (de) * 2013-12-20 2026-05-06 Agenebio, Inc. Benzodiazepinderivate, zusammensetzungen und verfahren zur behandlung von kognitiven störungen
EP3310785B1 (de) 2015-06-19 2024-11-20 Agenebio, Inc. Benzodiazepinderivate, zusammensetzungen und verfahren zur behandlung kognitiver beeinträchtigung
EP3324976A4 (de) 2015-07-21 2019-03-27 Millennium Pharmaceuticals, Inc. Verabreichung eines aurora-kinase-inhibitors und chemotherapeutika
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AU2019288382B2 (en) 2018-06-19 2024-07-25 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
TW201311B (de) 1991-06-17 1993-03-01 Hoffmann La Roche
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
AU2793199A (en) * 1998-02-26 1999-09-15 Neurogen Corporation 2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives,their preparation and their use as (ant-)agonists for gaba (a) brain receptors
US6177569B1 (en) * 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
AU1481701A (en) 1999-11-12 2001-06-06 Neurogen Corporation Bicyclic and tricyclic heteroaromatic compounds
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
GT200200087A (es) 2003-06-19
SI1399448T1 (en) 2005-02-28
RU2003136078A (ru) 2005-05-27
HUP0400743A3 (en) 2007-09-28
CZ20033355A3 (en) 2004-07-14
ECSP034851A (es) 2003-12-24
JP2004531563A (ja) 2004-10-14
CA2446903C (en) 2008-12-30
EP1399448B1 (de) 2004-12-01
HUP0400743A2 (hu) 2004-07-28
ES2232778T3 (es) 2005-06-01
NO20035104D0 (no) 2003-11-17
ZA200308544B (en) 2005-01-31
KR20040002975A (ko) 2004-01-07
PA8545201A1 (es) 2003-02-28
PE20030041A1 (es) 2003-02-07
DE60202147T2 (de) 2005-12-01
SK15252003A3 (sk) 2004-08-03
MXPA03010529A (es) 2004-03-02
NZ529097A (en) 2005-04-29
CN1230436C (zh) 2005-12-07
CA2446903A1 (en) 2002-11-28
MA27024A1 (fr) 2004-12-20
BR0209859A (pt) 2004-06-15
DE60202147D1 (de) 2005-01-05
HRP20030890A2 (en) 2005-08-31
DK1399448T3 (da) 2005-04-11
AU2002338898B8 (en) 2002-12-03
JP4068466B2 (ja) 2008-03-26
NO20035104L (no) 2003-11-17
US6686352B2 (en) 2004-02-03
PT1399448E (pt) 2005-03-31
HK1066544A1 (en) 2005-03-24
KR100533406B1 (ko) 2005-12-02
YU90003A (sh) 2006-08-17
MY127570A (en) 2006-12-29
JO2297B1 (en) 2005-09-12
US20030055042A1 (en) 2003-03-20
IL158572A (en) 2010-02-17
AU2002338898B2 (en) 2007-03-15
RU2287531C2 (ru) 2006-11-20
WO2002094834A1 (en) 2002-11-28
EP1399448A1 (de) 2004-03-24
AR033753A1 (es) 2004-01-07
TWI251489B (en) 2006-03-21
IL158572A0 (en) 2004-05-12
BG108369A (bg) 2005-01-31
CN1509289A (zh) 2004-06-30
PL366846A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
DE60103776D1 (de) Benzodiazepinderivate als gaba-a-rezeptormodulatoren
PT1444215E (pt) Derivados de 1,2,4-triadiazolio como moduladores do receptor de melanocortina
PT1218378E (pt) Derivados de terc-butil-(7-metil-imidazo-¬1,2-a|-piridin-3-il)-amina
DE60202200D1 (de) Imidazo[1,2-a]-pyridinderivate als mglur5 antagonisten
DE60202147D1 (de) Imidazo(1,5-a!pyrimido)5,4-d!benz azepinderivate als gaba-a-rezeptormodulatoren
NO20022738D0 (no) Pyrrolo(2,3-d)pyrimidinforbindelser
NO20043064L (no) 1-alkyl-1-azoniabisyklo [2.2.2] oktankarbamatderivater og anvendelse av disse som muskarine reseptorantagonister
NO20013671D0 (no) Substituerte bicycliske derivater nyttige som anticancer midler
DE60216115D1 (de) BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
DZ3377A1 (fr) Azaindoles
ATE253067T1 (de) Diazabicyloderivate als nikotin-acetylcholin- rezeptorliganden
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
DE60207241D1 (de) 5-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidin-derivate
IT1308096B1 (it) Convertiplano
NO20024006L (no) Adenosinreseptor modulatorer
ATE381565T1 (de) 1,3,8-triaza-spiro 4,5 decan-4-onderivative als neurokininrezeptorantagonisten
MA27043A1 (fr) Azaindoles
DE50202178D1 (de) Neue sulfonat-substituierte pyrazolopyridinderivate
DE60022893D1 (de) Naphthyridinverbindungen
NO20013456D0 (no) Funksjonaliserte heterocykler som chemokin-reseptor- modulatorer
NO20013997L (no) Reseptoranalyse
DK1210349T3 (da) Pyrazolo[4,3-d]pyrimidiner
PT1171419E (pt) Derivados de bifenilo como antagonistas do receptor da neuroquinina-1
DE60214408D1 (de) 5-METHOXY-8-ARYL-i1,2,4öTRIAZOLOi1,5-AöPYRIDINE DERIVATIVE ALS ADENOSIN-REZEPTOR ANTAGONISTEN
NO20021295D0 (no) Nikotinsyreacetylcholin-reseptor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1399448

Country of ref document: EP

REN Ceased due to non-payment of the annual fee